Tilray Brands Stock Forecast
NASDAQ: TLRYHealth Care Medicinal Chemicals and Botanical Products USD
Market open · Delayed 15 min · as of Oct 9, 1:51 PM ET
TLRY analyst consensus
Consensus (6 analysts)
buy
Avg. price target
$7.16+104.57%
- Strong buy 0
- Buy 3
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 6 Wall Street analysts covering Tilray Brands (2026-10-08), 3 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $7.16, with a high estimate of $17.00 and a low estimate of $4.00. The average target implies upside of 104.6% from the current price of $3.50.
The spread between the highest and lowest targets is 325.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for TLRY.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 3 | 50% |
| Hold | 3 | 50% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $4.00 | +14.29% |
| Average target | $7.16 | +104.57% |
| High target | $17.00 | +385.71% |